DIN/PIN Detail - 02377233

200000   BLOOD FORMULATION, COAGULATION AND THROMBOSIS
201200   ANTITHROMBOTIC AGENTS
201204   ANTICOAGULANTS
20120492   MISCELLANEOUS ANTICOAGULANTS

ELIQUIS 2.5 MG ORAL TABLET

(APIXABAN)

Manufacturer:
BRISTOL-MYERS SQUIBB
ECDET Review Status/Past Decision(s):
N/A
CDR Status/Past Decision(s):

 2015/10/01 - Special Authorization Criteria Change


 2015/09/01 - Under Review


 CDR - List with clinical criteria and/or conditions


 CDR - List with criteria/condition


 CDR - List with criteria/condition


To return to the printable Drug Benefit List and related publications, click here.

Last Updated: null

NOTICE:
The DBL, DBS and related publications require knowledgeable interpretation and are intended primarily for professional health care practitioners, pharmacies, hospitals and organizations associated with the manufacture, distribution and use of pharmaceutical preparations.

Electronic versions of all DBL and DBS related publications are unofficial versions and are provided for convenience and private use only. Official paper versions can be obtained from Alberta Blue Cross who publishes them on behalf of Alberta Health and Alberta Human Services.

Alberta Health reserves the right to make changes, without notice, to the List through the Interactive DBL(iDBL), and any such changes to the Interactive DBL(iDBL) are effective the date of the change (unless otherwise stated) and regardless of the date of publication in the paper version or updates.